Cleanspace Holdings Ltd. · ASX:CSX
Cleanspace — H1 FY2023 Earnings Presentation
10 slides from Cleanspace's earnings presentation, Feb 20, 2023
Slide 1: Half Year FY23 Results Presentation
HALF YEAR FY23 RESULTS PRESENTATION CLEANSPACE HOLDINGS LIMITED (ASX:CSX) CleanSpace designs and manufactures innovative respiratory protection solutions for healthcare & industrial employers globally We understand the importance of best-in-class personal protective equipment that not only performs,
Slide 2: Important Notice & Disclaimer
IMPORTANT NOTICE & DISCLAIMER ACCEPTANCE differ from the figures set out in this presentation. This presentation has been prepared by CleanSpace Holdings Limited (ACN 150 214 636) (CleanSpace). PAST PERFORMANCE By accepting, accessing or reviewing this presentation, you acknowledge and agree to the
Slide 3: Overview
OVERVIEW FINANCIAL RESULTS ▪ Revenue $5.7m (down 19% on PCP) ▪ Operating expenses $10.3m (14% lower than PCP) ▪ Operating EBITDA loss of -$6.3m (5% favourable v PCP) ▪ Cash in bank $16.4m KEY HIGHLIGHTS ▪ Industrial sales +65% v PCP ▪ Healthcare sales significantly down ▪ Cost reduction program deli
Slide 4: FY23 Interim Results Summary
FY23 INTERIM RESULTS SUMMARY Sector Sales: INDUSTRIAL REVENUE GROWTH ▪ Industrial 65% growth globally, growth in all regions ▪ Industrial revenue contributed 90% of total sales 65 % 70% GROSS MARGIN ▪ Healthcare sales were significantly down, reflecting lower demand post pandemic UP ON PCP 2 45% Reg
Slide 5: Operational Update – Sales, Products & Markets
OPERATIONAL UPDATE – SALES, PRODUCTS & MARKETS ▪ Steady recovery of the industrial markets in Europe, North America and Australia ▪ Purchasing patterns stabilised as customers recovered from supply chain and pandemic disruption ▪ Healthcare remained challenged as pandemic related dynamics persist Ke
Slide 6: Operational Update – Costs & Cash
OPERATIONAL UPDATE – COSTS & CASH ▪ Cost and Cash Management Initiatives ▪ Costs 14% lower than PCP despite US headcount investment Key Initiatives ▪ Headcount reduction of 20% ▪ US team change – exit of US Vice President (Jan 23) ▪ Marketing focus on digital ▪ Efficiencies in back office and manufa
Slide 7: Income Statement Summary
INCOME STATEMENT SUMMARY Change Change (A$m) 1H FY23 1H FY22 vs PCP 2H FY22 vs prior half ▪ Overall revenue down on PCP. Increase in F / ( U) % F / ( U) % Industrial revenue did not offset decline in healthcare sales in H1FY23 Revenue 5.7 7.0 (19) 6.4 (9) ▪ Maintained high gross margin (70%) Gross P
Slide 8: Summary Balance Sheet
SUMMARY BALANCE SHEET as at as at Summary Balance Sheet (A$m) ▪ Strong balance sheet. Net assets of $25.2m and Cash of 31-Dec-22 30-Jun-22 $16.4m Cash, cash equivalents and term deposits 16.4 24.3 ▪ Managing cash flow by optimising cost structure to re- Trade and other receivables 3.2 2.5 deploy fun
Slide 9: Outlook
OUTLOOK CleanSpace is committed to technology leadership to drive sales growth and financial performance as it supports ‘best in class’ premium respiratory protection for workers in high-risk settings CleanSpace has: ▪ Best in class premium respiratory products ▪ High margins ▪ A strong balance shee
Slide 10: www.cleanspacetechnology.com
WWW.CLEANSPACETECHNOLOGY.COM 10 CleanSpace Holdings Limited | 1H FY23 Results Presentation | February 2023
Cleanspace Holdings — H1 FY2023 Earnings Presentation on 6ix